Accuracy and Safety of a Novel Intravenous Continuous Glucose Monitoring System in Patients Admitted to a Cardiothoracic ICU: A Pilot Trial
The present findings indicate that the investigated intravenous glucose monitoring system provides accurate glucose monitoring and demonstrates its safety in critical care settings. This technology offers promise for improved glycemic management in critically ill patients, particularly those with diabetes, potentially mitigating the associated risks and complications.
Authors
- Felix Aberer (ORCID: https://orcid.org/0000-0002-9947-1413)
- Ingeborg M. Keeling (ORCID: https://orcid.org/0000-0003-2971-8422)
- Fausto Lucarelli
- Michael Schöerghuber
- Daniel Zimpfer (ORCID: https://orcid.org/0000-0002-2185-4895)
- Daniel A. Hochfellner (ORCID: https://orcid.org/0000-0003-4872-8861)
- Ameli Yates
- Julia Katharina Mader (ORCID: https://orcid.org/0000-0001-7854-4233)
- Francesca Berti (ORCID: https://orcid.org/0000-0001-8621-2503)
- Tina Poettler
- Edita Lukić (ORCID: https://orcid.org/0009-0002-6591-6805)
- Francesco Valgimigli
Institutions
- Medical University of Graz (AT)
- Menarini Group (Italy) (IT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Journal of Diabetes Science and Technology
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1177/19322968251342598
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 0.00